This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1998 Nov 7;352(9139):1486-7.

doi: 10.1016/S0140-6736(98)00057-9.

Interferon beta therapy for multiple sclerosis

Affiliations

PMID: 9820292
DOI: 10.1016/S0140-6736(98)00057-9

Clinical Trial

Interferon beta therapy for multiple sclerosis

D E Goodkin. Lancet. 1998.

. 1998 Nov 7;352(9139):1486-7.

doi: 10.1016/S0140-6736(98)00057-9.

Author

Affiliation

¹ MS Center, Department of Neurology, University of California San Francisco, 94115, USA.

PMID: 9820292
DOI: 10.1016/S0140-6736(98)00057-9

No abstract available

PubMed Disclaimer

Comment in

Interferon beta treatment for multiple sclerosis.
Johnson KP, Panitch HS. Johnson KP, et al. Lancet. 1999 Feb 6;353(9151):494; author reply 497-8. doi: 10.1016/S0140-6736(99)00025-2. Lancet. 1999. PMID: 9989738 No abstract available.
Interferon beta treatment for multiple sclerosis.
Galazka A. Galazka A. Lancet. 1999 Feb 6;353(9151):495; author reply 497-8. doi: 10.1016/S0140-6736(05)75164-3. Lancet. 1999. PMID: 9989740 No abstract available.
Interferon beta treatment for multiple sclerosis.
O'Connor P. O'Connor P. Lancet. 1999 Feb 6;353(9151):496; author reply 497-8. doi: 10.1016/S0140-6736(05)75166-7. Lancet. 1999. PMID: 9989742 No abstract available.
Interferon beta treatment for multiple sclerosis.
Forbes RB, Swingler RJ. Forbes RB, et al. Lancet. 1999 Feb 6;353(9151):496-8. doi: 10.1016/S0140-6736(05)75167-9. Lancet. 1999. PMID: 9989743 No abstract available.
Provision of treatment for multiple sclerosis.
Compston A. Compston A. Lancet. 1999 May 15;353(9165):1710-1. doi: 10.1016/S0140-6736(05)77022-7. Lancet. 1999. PMID: 10335817 No abstract available.

Comment on

Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS.
[No authors listed] [No authors listed] Lancet. 1998 Nov 7;352(9139):1491-7. Lancet. 1998. PMID: 9820296 Clinical Trial.
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
[No authors listed] [No authors listed] Lancet. 1998 Nov 7;352(9139):1498-504. Lancet. 1998. PMID: 9820297 Clinical Trial.

Publication types

Actions
Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information